Literature DB >> 30877885

Mutually assured destruction: the cold war between viruses and natural killer cells.

Ayad Ali1, Ivayla E Gyurova2, Stephen N Waggoner3.   

Abstract

Natural killer (NK) cells play a multitude of antiviral roles that are significant enough to provoke viral counterefforts to subvert their activity. As innate lymphocytes, NK cells provide a rapid source of pro-inflammatory antiviral cytokines and bring to bear cytolytic activities that are collectively meant to constrain viral replication and dissemination. Additionally, NK cells participate in adaptive immunity both by shaping virus-specific T-cell responses and by developing adaptive features themselves, including enhanced antibody-dependent effector functions. The relative importance of different functional activities of NK cells are poorly understood, thereby obfuscating clinical use of these cells. Here we focus on opposing efforts of NK cells and viruses to gain tactical superiority during infection.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30877885      PMCID: PMC6476651          DOI: 10.1016/j.coviro.2019.02.005

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  145 in total

1.  Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Authors:  Charles L Dulberger; Curtis P McMurtrey; Angelique Hölzemer; Karlynn E Neu; Victor Liu; Adriana M Steinbach; Wilfredo F Garcia-Beltran; Michael Sulak; Bana Jabri; Vincent J Lynch; Marcus Altfeld; William H Hildebrand; Erin J Adams
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

2.  NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.

Authors:  Mohammad Diab; Ariella Glasner; Batya Isaacson; Yotam Bar-On; Yaron Drori; Rachel Yamin; Alexandra Duev-Cohen; Oded Danziger; Rachel Zamostiano; Michal Mandelboim; Stipan Jonjic; Eran Bacharach; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2017-03-06       Impact factor: 5.532

Review 3.  Epigenetic Regulation of Adaptive NK Cell Diversification.

Authors:  Bianca Tesi; Heinrich Schlums; Frank Cichocki; Yenan T Bryceson
Journal:  Trends Immunol       Date:  2016-05-06       Impact factor: 16.687

4.  Biallelic mutations in IRF8 impair human NK cell maturation and function.

Authors:  Emily M Mace; Venetia Bigley; Justin T Gunesch; Ivan K Chinn; Laura S Angelo; Matthew A Care; Sheetal Maisuria; Michael D Keller; Sumihito Togi; Levi B Watkin; David F LaRosa; Shalini N Jhangiani; Donna M Muzny; Asbjørg Stray-Pedersen; Zeynep Coban Akdemir; Jansen B Smith; Mayra Hernández-Sanabria; Duy T Le; Graham D Hogg; Tram N Cao; Aharon G Freud; Eva P Szymanski; Sinisa Savic; Matthew Collin; Andrew J Cant; Richard A Gibbs; Steven M Holland; Michael A Caligiuri; Keiko Ozato; Silke Paust; Gina M Doody; James R Lupski; Jordan S Orange
Journal:  J Clin Invest       Date:  2016-11-28       Impact factor: 14.808

5.  Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.

Authors:  Sinéad E Keating; Vanessa Zaiatz-Bittencourt; Roisín M Loftus; Ciara Keane; Kiva Brennan; David K Finlay; Clair M Gardiner
Journal:  J Immunol       Date:  2016-02-12       Impact factor: 5.422

6.  Type I interferons enhance production of IFN-gamma by NK cells.

Authors:  C A Hunter; K E Gabriel; T Radzanowski; L E Neyer; J S Remington
Journal:  Immunol Lett       Date:  1997-10       Impact factor: 3.685

7.  Infection of natural killer cells by human herpesvirus 6.

Authors:  P Lusso; M S Malnati; A Garzino-Demo; R W Crowley; E O Long; R C Gallo
Journal:  Nature       Date:  1993-04-01       Impact factor: 49.962

8.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors:  Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

9.  Modulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells.

Authors:  Kattria van der Ploeg; Chiwen Chang; Martin A Ivarsson; Ashley Moffett; Mark R Wills; John Trowsdale
Journal:  Front Immunol       Date:  2017-03-29       Impact factor: 7.561

10.  Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.

Authors:  Veron Ramsuran; Vivek Naranbhai; Amir Horowitz; Ying Qi; Maureen P Martin; Yuko Yuki; Xiaojiang Gao; Victoria Walker-Sperling; Gregory Q Del Prete; Douglas K Schneider; Jeffrey D Lifson; Jacques Fellay; Steven G Deeks; Jeffrey N Martin; James J Goedert; Steven M Wolinsky; Nelson L Michael; Gregory D Kirk; Susan Buchbinder; David Haas; Thumbi Ndung'u; Philip Goulder; Peter Parham; Bruce D Walker; Jonathan M Carlson; Mary Carrington
Journal:  Science       Date:  2018-01-04       Impact factor: 47.728

View more
  12 in total

1.  High-Resolution Analysis Identifies High Frequency of KIR-A Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han.

Authors:  Sudan Tao; Yanmin He; Katherine M Kichula; Jielin Wang; Ji He; Paul J Norman; Faming Zhu
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

2.  Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.

Authors:  Belinda M Jackson-Thompson; Emilie Goguet; Eric D Laing; Cara H Olsen; Simon Pollett; K Monique Hollis-Perry; Santina E Maiolatesi; Luca Illinik; Kathleen F Ramsey; Anatalio E Reyes; Yolanda Alcorta; Mimi A Wong; Julian Davies; Orlando Ortega; Edward Parmelee; Alyssa R Lindrose; Matthew Moser; Elizabeth Graydon; Andrew G Letizia; Christopher A Duplessis; Anuradha Ganesan; Kathleen P Pratt; Allison M Malloy; David W Scott; Stephen K Anderson; Andrew L Snow; Clifton L Dalgard; John H Powers; David Tribble; Timothy H Burgess; Christopher C Broder; Edward Mitre
Journal:  BMC Infect Dis       Date:  2021-06-09       Impact factor: 3.090

Review 3.  Targeting natural killer cells to enhance vaccine responses.

Authors:  Andrew Cox; Hilal Cevik; H Alex Feldman; Laura M Canaday; Nora Lakes; Stephen N Waggoner
Journal:  Trends Pharmacol Sci       Date:  2021-07-23       Impact factor: 17.638

Review 4.  NK Cell-Based Immunotherapy in Renal Cell Carcinoma.

Authors:  Iñigo Terrén; Ane Orrantia; Idoia Mikelez-Alonso; Joana Vitallé; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

Review 5.  The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy.

Authors:  Paola Fisicaro; Marzia Rossi; Andrea Vecchi; Greta Acerbi; Valeria Barili; Diletta Laccabue; Ilaria Montali; Alessandra Zecca; Amalia Penna; Gabriele Missale; Carlo Ferrari; Carolina Boni
Journal:  Int J Mol Sci       Date:  2019-10-13       Impact factor: 5.923

Review 6.  Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment.

Authors:  Nicolas Ripari; Arthur Alves Sartori; Mariana da Silva Honorio; Fernanda Lopes Conte; Karen Ingrid Tasca; Karina Basso Santiago; José Maurício Sforcin
Journal:  J Pharm Pharmacol       Date:  2021-03-06       Impact factor: 3.765

7.  Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.

Authors:  Ganna Galitska; Alessandra Coscia; Diego Forni; Lars Steinbrueck; Simone De Meo; Matteo Biolatti; Marco De Andrea; Rachele Cagliani; Agata Leone; Enrico Bertino; Thomas Schulz; Angela Santoni; Santo Landolfo; Manuela Sironi; Cristina Cerboni; Valentina Dell'Oste
Journal:  Front Immunol       Date:  2021-04-09       Impact factor: 7.561

8.  Generation and characterization of an I l2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients.

Authors:  Rong Li; Baoling Ying; Yanan Liu; Jacqueline F Spencer; Jinxin Miao; Ann E Tollefson; James D Brien; Yaohe Wang; William S M Wold; Zhongde Wang; Karoly Toth
Journal:  Dis Model Mech       Date:  2020-08-27       Impact factor: 5.758

9.  How I Manage Natural Killer Cell Deficiency.

Authors:  Jordan S Orange
Journal:  J Clin Immunol       Date:  2019-11-22       Impact factor: 8.317

10.  Innate Cytokine Induced Early Release of IFNγ and CC Chemokines from Hypoxic Human NK Cells Is Independent of Glucose.

Authors:  Sonia Y Velásquez; Bianca S Himmelhan; Nina Kassner; Anna Coulibaly; Jutta Schulte; Kathrin Brohm; Holger A Lindner
Journal:  Cells       Date:  2020-03-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.